Harold David McIntyre,Jeremy J. N. Oats,Anne B. Kihara,Hema Divakar,Anil Kapur,Liona C. Poon,Moshe Hod
doi : 10.1002/ijgo.13764
Volume 154, Issue 2 p. 189-194
Limei Wu,Wanchun Xiong,Manman Zeng,Aihua Yan,Ling Song,Meng Chen,Tianqin Wei,Qian Zu,Jiayin Zhang
doi : 10.1002/ijgo.13541
Volume 154, Issue 2 p. 195-203
To compare 1- and 2-day drug administration interval between mifepristone and misoprostol for second-trimester pregnancy termination and provide evidence-based recommendations.
Angela J. Reichelt,Vânia N. Hirakata,Vanessa K. Genro,Maria L?cia R. Oppermann
doi : 10.1002/ijgo.13714
Volume 154, Issue 2 p. 204-211
Some maternal characteristics indicate worse prognosis in pregnant women with coronavirus disease 2019 (COVID-19).
Marco La Verde,Gaetano Riemma,Marco Torella,Stefano Cianci,Fabiana Savoia,Federico Licciardi,Serena Scida,Maddalena Morlando,Nicola Colacurci,Pasquale De Franciscis
doi : 10.1002/ijgo.13726
Volume 154, Issue 2 p. 212-219
Besides reducing the quality of obstetric care, the direct impact of COVID-19 on pregnancy and postpartum is uncertain.
Mathew Nyashanu,Rumbidzai Chireshe,Fungisai Mushawa,Mandu S. Ekpenyong
doi : 10.1002/ijgo.13771
Volume 154, Issue 2 p. 220-226
To explore the challenges of women taking antiretroviral treatment (ART) during the COVID-19 pandemic lockdown in a peri-urban area.
Hyun-Woong Cho,Jin Hwa Hong,Jae Kwan Lee
doi : 10.1002/ijgo.13583
Volume 154, Issue 2 p. 227-232
To identify high-risk HPV (hrHPV) genotypes associated with high-grade vaginal intraepithelial neoplasia (VaIN), and evaluate the efficacy of various treatments for high-grade VaIN.
David Sheyn,Ryan Darvish,Lalitha Nayak,Sara Myer,Caitlin Claridge,C. Emi Bretschneider
doi : 10.1002/ijgo.13582
Volume 154, Issue 2 p. 233-240
To determine whether mild or moderate thrombocytopenia is associated with postoperative complications after benign hysterectomy.
Cheng-chao Du,Yu-qi Wang,Da-cheng Qu,Liu-peng Jiang,Xin Yu,Hong-gui Zhou
doi : 10.1002/ijgo.13587
Volume 154, Issue 2 p. 241-247
To investigate the relationship between the number of hyperintense foci of T2-weighted imaging (T2WI) and the efficacy of high-intensity focused ultrasound (HIFU) in the treatment of adenomyosis.
Hannah Donkers,Kristine E. Fasmer,John Mcgrane,Johanna M. A. Pijnenborg,Ruud Bekkers,Ingfrid S. Haldorsen,Khadra Galaal
doi : 10.1002/ijgo.13591
Volume 154, Issue 2 p. 248-255
To investigate the relationship between obesity and sarcopenia in relation to overall survival (OS) and disease-specific survival (DSS) in high-grade endometrial cancer patients.
Mandisa Singata-Madliki,Florence Carayon-Lefebvre d’Hellencourt,Theresa A. Lawrie,Yusentha Balakrishna,G. Justus Hofmeyr
doi : 10.1002/ijgo.13594
Volume 154, Issue 2 p. 256-262
To compare the effects of depot medroxyprogesterone acetate (DMPA-IM), levonorgestrel (LNG) implant, and copper intrauterine device (IUD) on mood and sexual function.
Ahmed I. Hassanin,Ahmed A. Youssef,Asmaa M. Yousef,Mohammed K. Ali
doi : 10.1002/ijgo.13600
Volume 154, Issue 2 p. 263-269
To compare the efficacy and safety of dienogest with combined oral contraceptives (COCs) for treating adenomyosis-associated symptoms.
Julia Kramer
doi : 10.1002/ijgo.13601
Volume 154, Issue 2 p. 270-276
Both Rwanda and Australia have made significant strides to eradicate cervical cancer. To understand the successes in Rwanda and Australia, a comparative policy analysis was conducted based on key informant interviews and a review of peer-reviewed literature and policy briefs. Notable findings were identified that offer lessons for countries across the income spectrum. To address cervical cancer, low- and middle-income countries can leverage foreign aid, international collaboration, and strong political advocacy, as Rwanda did. High-income countries can invest in translational research that builds capacity from basic science research to implementation of novel and impactful health products and services, as Australia did. All countries can consider rolling out HPV vaccination by targeting the social and/or physical environment (e.g., a school-based vaccination program, as both Rwanda and Australia did). Cervical cancer is preventable, and eradication is within reach for countries across the income spectrum around the world. Cervical cancer screening programs are needed to minimize the incidence of and mortality from cervical cancer in the short term, and HPV vaccination programs are the best strategy to eradicate cervical cancer in the long term.
Sergey V. Barinov,Yuliya I. Tirskaya,Anna V. Borisova,Lidiya G. Pyanova,Gian Carlo Di Renzo
doi : 10.1002/ijgo.13609
Volume 154, Issue 2 p. 277-284
To improve the management of patients with chronic endometritis (CE) by using a molded sorbent—modified by polyvinylpyrrolidone (FSMP).
Bar Zemer Tov,Asnat Walfisch,Naama Schwartz,Hila Meir,Vered Kleitman
doi : 10.1002/ijgo.13679
Volume 154, Issue 2 p. 285-290
Cytomegalovirus (CMV) seroconversion in pregnancy is a major health issue with potentially devastating fetal consequences. We opted to determine rates and trends of CMV seroconversion in pregnant army personnel and to isolate risk factors.
Sule Goncu Ayhan,Deniz Oluklu,Aysegul Atalay,Dilek Menekse Beser,Atakan Tanacan,Ozlem Moraloglu Tekin,Dilek Sahin
doi : 10.1002/ijgo.13713
Volume 154, Issue 2 p. 291-296
To determine vaccine acceptance and hesitancy attitudes toward coronavirus disease 2019 (COVID-19) vaccines in pregnant women.
Lior Friedrich,Gabriel Levin,Nitzan Maixner,Yossi Bart,Abraham Tsur,Yoav Yinon,Raanan Meyer
doi : 10.1002/ijgo.13715
Volume 154, Issue 2 p. 297-303
Sherif A. Shazly,Ismet Hortu,Jin-Chung Shih,Rauf Melekoglu,Shangrong Fan,Farhat ul Ain Ahmed,Erbil Karaman,Ildar Fatkullin,Pedro V. Pinto,Setyorini Irianti,Joel Noutakdie Tochie,Amr S. Abdelbadie,Mohamed A. Salah,Hossam Aldein S. Abd Elazeem,Mahmoud M. Saad,Ahmet M. Ergenoglu,Ahmet O. Yeniel,Sermet Sagol,Ismail M. Itil,Jessica Kang,Kuan-Ying Huang,Ercan Yilmaz,Yiheng Liang,Hijab Aziz,Tayyiba Akhter,Afshan Ambreen,?a?r? Ate?,Yasemin Karaman,Albir Khasanov,Larisa Fatkullina,Nariman Akhmadeev,Adelina Vatanina,Ana Paula Machado,Nuno Montenegro,Jusuf S. Effendi,Dodi Suardi,Ahmad Y. Pramatirta,Muhamad A. Aziz,Amilia Siddiq,Ingrid Ofakem,Julius Sama Dohbit,Mohamed S. Fahmy,Mohamed A. Anan
doi : 10.1002/ijgo.13518
Volume 154, Issue 2 p. 304-311
To create a model for prediction of success of uterine-preserving procedures in women with placenta accreta spectrum (PAS).
Tanvi Katoch,Anju Singh,Vanita Suri,Sunil Sethi,Naresh Sachdeva,Shano Naseem
doi : 10.1002/ijgo.13525
Volume 154, Issue 2 p. 312-317
Maternal sepsis is a life-threatening condition. Biomarkers have been found to be useful in early detection of sepsis in the critical care setting. We aimed to determine the diagnostic performance of different biomarkers such as procalcitonin, C-reactive protein (CRP), absolute eosinophil count, and activated partial thromboplastin time (aPTT) in maternal sepsis.
Bernadether T. Rugumisa,Erik Bongcam-Rudloff,Murate S. Lukumay,Sylvester L. Lyantagaye
doi : 10.1002/ijgo.13520
Volume 154, Issue 2 p. 318-323
To determine factors associated with risk of preterm delivery among pregnant women delivering at Muhimbili National Hospital in Tanzania.
Uchenna K. Ezemagu,Godwin C. Uzomba,Ubochi Chuwkuemeka,Ogbu Rachel,Egba C. Friday,Olisa Onuora
doi : 10.1002/ijgo.13527
Volume 154, Issue 2 p. 324-330
To assess the input of maternal and neonatal body physique anthropometries to birth outcomes.
George N. Gwako,Moses M. Obimbo,Peter B. Gichangi,John Kinuthia,Onesmus W. Gachuno,Fredrick Were
doi : 10.1002/ijgo.13528
Volume 154, Issue 2 p. 331-336
To evaluate the association between obstetric and medical risk factors and stillbirths in a Kenyan set-up.
Yi Zhang,Fangrong Shen,Weiwen Yang,Juan Wang,Jinhua Zhou,Youguo Chen
doi : 10.1002/ijgo.13535
Volume 154, Issue 2 p. 337-342
To evaluate the effects of low-molecular-weight heparin (LMWH) combined with low-dose aspirin (LDA) in pregnant women with a history of pregnancy-related hypertensive disorders.
Nalini Mishra,Suma V. Ekka,Sanjita Pal,Ishan Mishra
doi : 10.1002/ijgo.13536
Volume 154, Issue 2 p. 343-351
To study the correlation of conventional point-of-care clotting test (POCCT) of whole blood with laboratory fibrinogen levels in women with primary major postpartum hemorrhage (PPH) to generate evidence regarding its potential in rationalizing transfusion of blood components for supplementing fibrinogen.
Fiona Cody,Sieglinde Mullers,Karen Flood,Julia Unterscheider,Sean Daly,Michael Geary,Mairead Kennelly,Fionnuala McAuliffe,Keelin O’Donoghue,Alyson Hunter,John Morrison,Gerard Burke,Patrick Dicker,Elizabeth Tully,Fergal Malone,Perinatal Ireland Research Consortium
doi : 10.1002/ijgo.13586
Volume 154, Issue 2 p. 352-357
To evaluate the correlation between umbilical artery (UA) Doppler and its feasibility across categories of maternal body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters) in the presence of fetal growth restriction (FGR).
Emma R. Lawrence,Anna Stabnick,Johnny Arthur-Komeh,Cheryl A. Moyer,Michael Yeboah
doi : 10.1002/ijgo.13537
Volume 154, Issue 2 p. 358-365
This study explores the impacts of managing frequent maternal mortalities on obstetric healthcare providers in Ghana.
Matija Prka,Albert Despot,Alemka Brn?i? Fischer,Herman Haller,Ana Tikvica Lueti?,Dubravko Habek
doi : 10.1002/ijgo.13734
Volume 154, Issue 2 p. 366-367
Abhiram Kanneganti,Ida Ismail-Pratt,Nooraishah Yasin,Jeffrey J. H. Low
doi : 10.1002/ijgo.13762
Volume 154, Issue 2 p. 368-369
Natalia Abad?a-Cuch?,Sara Ruiz-Mart?nez,Marta Fabre,Purificaci?n Mateo,Mar?a Remacha Sienes,Purificaci?n Ventura Faci,Jessica Bueno Sancho,Rafael Benito,Cristina Paules
doi : 10.1002/ijgo.13749
Volume 154, Issue 2 p. 370-372
Mingwang Jia,Zhaohui Gan,Xitu Luo,Han Xie,Yichun Wang,Dunjin Chen
doi : 10.1002/ijgo.13741
Volume 154, Issue 2 p. 372-374
Peter Edward Hall
doi : 10.1002/ijgo.13748
Volume 154, Issue 2 p. 374-375
Giorgia Far?,Marco Dell’Aquila,Sascia Moresi,Antonio Lanzone,Vincenzo Arena
doi : 10.1002/ijgo.13765
Volume 154, Issue 2 p. 376-378
Alison Spillane,Maeve Taylor,Caitriona Henchion,R?is?n Venables,Catherine Conlon
doi : 10.1002/ijgo.13720
Volume 154, Issue 2 p. 379-384
Early abortion care became available in Ireland in January 2019. Service delivery involves two consultations with a medical practitioner, separated by a mandatory 3-day waiting period. The Model of Care for termination of pregnancy initially required in-person visits. The onset of the COVID-19 pandemic necessitated significant reductions in in-person interactions in healthcare. A revised Model of Care for termination of pregnancy, issued for the duration of the pandemic, permits delivery of early abortion care by remote consultation. Significantly, this was introduced without amending the 2018 abortion law. The pandemic precipitated a rapid development in the delivery of abortion care that was not anticipated at the time of abortion law reform only 18 months earlier. We outline the work undertaken to maintain access to abortion care in early pregnancy through the lens of a single community-level provider and explore what these developments may mean for abortion law, policy, and service delivery.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟